151 related articles for article (PubMed ID: 34526525)
21. First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial.
Morscher RJ; Brard C; Berlanga P; Marshall LV; André N; Rubino J; Aerts I; De Carli E; Corradini N; Nebchi S; Paoletti X; Mortimer P; Lacroix L; Pierron G; Schleiermacher G; Vassal G; Geoerger B
Eur J Cancer; 2021 Nov; 157():268-277. PubMed ID: 34543871
[TBL] [Abstract][Full Text] [Related]
22. Therapy-related myeloid leukemia during erlotinib treatment in a non-small cell lung cancer patient: A case report.
Koo SM; Kim KU; Kim YK; Uh ST
World J Clin Cases; 2021 Aug; 9(24):7205-7211. PubMed ID: 34540979
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant therapy in non-small cell lung cancer: is targeted therapy joining the standard of care?
Gabay C; Russo A; Raez LE; Rolfo Cervetto C
Expert Rev Anticancer Ther; 2021 Nov; 21(11):1229-1235. PubMed ID: 34528869
[TBL] [Abstract][Full Text] [Related]
24. Metastatic Castration-Resistant Prostate Cancer Remains Dependent on Oncogenic Drivers Found in Primary Tumors.
Einstein DJ; Arai S; Calagua C; Xie F; Voznesensky O; Capaldo BJ; Luffman C; Hecht JL; Balk SP; Sowalsky AG; Russo JW
JCO Precis Oncol; 2021; 5():. PubMed ID: 34568716
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of Circular RNA circ_0013587 Reverses Erlotinib Resistance in Pancreatic Cancer Cells Through Regulating the miR-1227/E-Cadherin Pathway.
Xu H; Chen R; Shen Q; Yang D; Peng H; Tong J; Fu Q
Front Oncol; 2021; 11():754146. PubMed ID: 34552882
[TBL] [Abstract][Full Text] [Related]
26. Clinical and Pathologic Complete Response to Gefitinib in a Patient with SqCLC Harboring EGFR p.E746_S752delinsV Mutation.
Zhuang W; Zhang C; Tang Y; Tian D; Lan Z; Zeng C; Qiao G
Onco Targets Ther; 2021; 14():4805-4808. PubMed ID: 34552336
[TBL] [Abstract][Full Text] [Related]
27. Study of patient characteristics, treatment patterns,
Winfree KB; Sheffield KM; Cui ZL; Sugihara T; Feliciano J
Curr Med Res Opin; 2022 Jan; 38(1):91-99. PubMed ID: 34544302
[TBL] [Abstract][Full Text] [Related]
28. Pharmacophore based drug design and synthesis of oxindole bearing hybrid as anticancer agents.
Pathak A; Pandey V; Raj Pokharel Y; Devaraji V; Ali A; Haider K; Saad S; Dewangan RP; Siddiqui N; Shahar Yar M
Bioorg Chem; 2021 Nov; 116():105358. PubMed ID: 34544029
[TBL] [Abstract][Full Text] [Related]
29. Osimertinib plus platinum-pemetrexed in newly diagnosed epidermal growth factor receptor mutation-positive advanced/metastatic non-small-cell lung cancer: safety run-in results from the FLAURA2 study.
Planchard D; Feng PH; Karaseva N; Kim SW; Kim TM; Lee CK; Poltoratskiy A; Yanagitani N; Marshall R; Huang X; Howarth P; Jänne PA; Kobayashi K
ESMO Open; 2021 Oct; 6(5):100271. PubMed ID: 34543864
[TBL] [Abstract][Full Text] [Related]
30. Yang-Yin-Jie-Du decoction overcomes gefitinib resistance in non-small cell lung cancer via down-regulation of the PI3K/Akt signalling pathway.
Chen SY; Zhang GC; Shu QJ
Pharm Biol; 2021 Dec; 59(1):1294-1304. PubMed ID: 34543169
[TBL] [Abstract][Full Text] [Related]
31. Dysregulated androgen synthesis and anti-androgen resistance in advanced prostate cancer.
Armstrong CM; Gao AC
Am J Clin Exp Urol; 2021; 9(4):292-300. PubMed ID: 34541028
[TBL] [Abstract][Full Text] [Related]
32. Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden.
Fallara G; Alverbratt C; Garmo H; Vikman H; Hjelm Eriksson M; Lissbrant IF; Stattin P
Acta Oncol; 2021 Dec; 60(12):1589-1596. PubMed ID: 34533422
[TBL] [Abstract][Full Text] [Related]
33. Pyrotinib combined with thalidomide in advanced non-small-cell lung cancer patients harboring HER2 exon 20 insertions (PRIDE): protocol of an open-label, single-arm phase II trial.
Ai X; Song Z; Jian H; Zhou Z; Chen Z; Yu Y; Li Z; Lu S
BMC Cancer; 2021 Sep; 21(1):1033. PubMed ID: 34530760
[TBL] [Abstract][Full Text] [Related]
34. Pembrolizumab-Induced Meningoencephalitis: A Brain Autopsy Case.
Minami S; Okada H; Ihara S; Tsuji H; Yamadera M; Yasuoka H
J Med Cases; 2021 Sep; 12(9):359-365. PubMed ID: 34527106
[TBL] [Abstract][Full Text] [Related]
35. Submandibular excision with and without parotid duct ligation for sialorrhoea.
Thangirala A; Zhu H; Lambert EM
Br J Oral Maxillofac Surg; 2021 Dec; 59(10):1291-1295. PubMed ID: 34563353
[TBL] [Abstract][Full Text] [Related]
36. In vitro effects of bufotenine against RNA and DNA viruses.
Barboza CM; Pimenta DC; Vigerelli H; de Cássia Rodrigues da Silva A; Garcia JG; Zamudio RM; Castilho JG; Montanha JA; Roehe PM; de Carvalho Ruthner Batista HB
Braz J Microbiol; 2021 Dec; 52(4):2475-2482. PubMed ID: 34562234
[TBL] [Abstract][Full Text] [Related]
37. Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.
McBain C; Lawrie TA; Rogozińska E; Kernohan A; Robinson T; Jefferies S
Cochrane Database Syst Rev; 2021 May; 5(1):CD013579. PubMed ID: 34559423
[TBL] [Abstract][Full Text] [Related]
38. Supportive care for the prevention of nausea, vomiting and anorexia in a phase 1B study of selinexor in advanced cancer patients: an exploratory study.
Dev R; Zhong LL; Zarifa A; Albittar AA; Rubin L; Liu S; Yap TA; Dalal S; Hui D; Karp DD; Tsimberidou AM; Piha-Paul SA; Ahnert JR; Fu S; Meric-Bernstam F; Naing A
Invest New Drugs; 2022 Feb; 40(1):124-133. PubMed ID: 34559346
[TBL] [Abstract][Full Text] [Related]
39. Financial Burden of Drugs Prescribed for Cancer-Associated Symptoms.
Gupta A; Nshuti L; Grewal US; Sedhom R; Check DK; Parsons HM; Blaes AH; Virnig BA; Lustberg MB; Subbiah IM; Nipp RD; Dy SM; Dusetzina SB
JCO Oncol Pract; 2022 Feb; 18(2):140-147. PubMed ID: 34558297
[TBL] [Abstract][Full Text] [Related]
40. Risk of major bleeding associated with concomitant use of anticancer drugs and direct oral anticoagulant in patients with cancer and atrial fibrillation.
Wang CL; Wu VC; Tu HT; Huang YT; Chen SW; Chu PH; Wen MS; Huang HL; Chang SH
J Thromb Thrombolysis; 2022 Apr; 53(3):633-645. PubMed ID: 34557973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
